Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine

• मुख्य लेखकों: Zhigang Zhang (लेखक), Jun Zhang (लेखक), Ningshao Xia (लेखक), Qinjian Zhao (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Taylor & Francis Group, 2017-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Human papillomavirus is considered the causative factor for cervical cancer, which accounts for approximately 5% of the global cancer burden and more than 600,000 new cases annually that are attributable to HPV infection worldwide. The first-generation prophylactic HPV vaccines, Gardasil® and Cervar...